Viemed Healthcare, Inc. Common Shares earnings per share and revenue
On Mar 04, 2026, VMD reported earnings of 0.14 USD per share (EPS) for Q4 25, beating the estimate of 0.12 USD, resulting in a 10.85% surprise. Revenue reached 76.18 million, compared to an expected 78.48 million, with a -2.93% difference. The market reacted with a -7.49% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 2 analysts forecast an EPS of 0.09 USD, with revenue projected to reach 75.14 million USD, implying an decrease of -35.71% EPS, and decrease of -1.36% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Omeros Corporation
Report Date
Mar 31, 2026 For Q4 25
Estimate
-$0.58
Actual
$0.98
Surprise
+268.56%
Tilray Brands, Inc. Common Stock
Report Date
Apr 01, 2026 For Q3 26
Estimate
-$0.14
Actual
-$0.24
Surprise
-68.07%
FitLife Brands, Inc. Common Stock
Report Date
Mar 31, 2026 For Q4 25
Estimate
$0.21
Actual
$0.16
Surprise
-25.22%
Neogen Corp
Report Date
Apr 09, 2026 For Q3 26
Estimate
$0.05
Actual
$0.09
Surprise
+53.32%
IM Cannabis Corp. Common Shares
Report Date
Mar 30, 2026 For Q4 25
Estimate
$0.12
Actual
-$1.19
Surprise
-1055.53%
FAQ
What were Viemed Healthcare, Inc. Common Shares's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Viemed Healthcare, Inc. Common Shares reported EPS of $0.14, beating estimates by 10.85%, and revenue of $76.18M, -2.93% below expectations.
How did the market react to Viemed Healthcare, Inc. Common Shares's Q4 2025 earnings?
The stock price moved down -7.49%, changed from $9.08 before the earnings release to $8.40 the day after.
When is Viemed Healthcare, Inc. Common Shares expected to report next?
The next earning report is scheduled for May 05, 2026.
What are the forecasts for Viemed Healthcare, Inc. Common Shares's next earnings report?
Based on 2
analysts, Viemed Healthcare, Inc. Common Shares is expected to report EPS of $0.09 and revenue of $75.14M for Q1 2026.